Veradermics MANE Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's total operating expenses?
- Veradermics (MANE) reported total operating expenses of $29.86M in Q1 2026.
- How has Veradermics 's total operating expenses changed year-over-year?
- Veradermics 's total operating expenses increased by 131.2% year-over-year, from $12.92M to $29.86M.
- What does total operating expenses mean?
- The total cost of operating the business during a specific period.
- How do you interpret total operating expenses?
- Rising expenses relative to progress indicate higher cash burn, while stable or declining expenses suggest disciplined capital management.
- How does total operating expenses compare across companies?
- Early-stage biopharmaceutical companies typically report high operating expenses relative to revenue due to heavy R&D investment.